Truscreen GroupASX:TRU -7.14% Days Payable is 0.00 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Truscreen Group ranks better than 82.77% on this metric.
The historical rank and industry rank for Truscreen Group's Days Payable or its related term are showing as below:
ASX:TRU'
s Days Payable Range Over the Past 10 Years
Min: 131.45 Med: 240.32 Max: 385.49
Current: 182.96
During the past 12 years, Truscreen Group's highest Days Payable was 385.49. The lowest was 131.45. And the median was 240.32.
ASX:TRU's Days Payable is ranked better than 82.77% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs ASX:TRU: 182.96
Truscreen Group's Days Payable
declined
from Sep. 2024 (199.37) to Mar. 2026 (0.00).
It may suggest that Truscreen Groupaccelerated paying its suppliers.
Truscreen Group Days Payable Related Terms
Truscreen Group Days Payable Historical Data
* Premium members only.
The historical data trend for Truscreen Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Truscreen Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Truscreen Group Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Truscreen Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Truscreen Group's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Truscreen Group (ASX:TRU) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Truscreen Group and its competitors. Over the past decade, Truscreen Group's Days Payable has ranged from 131.45 to 385.49. According to the industry distribution chart, Truscreen Group ranks #137 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Truscreen Group's Days Payable too high?
Truscreen Group's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 131.45 to a high of 385.49. Based on the distribution chart, Truscreen Group ranks #137 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Truscreen Group's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Truscreen Group ranks #137 out of 795 companies for Days Payable. This places Truscreen Group in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Historically, Truscreen Group's own Days Payable has ranged from 131.45 to 385.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Truscreen Group and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Truscreen Group's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 30% above its estimated fair value. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRU has been successfully added to your 